Drugs / YD312
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03635814 | Oct 2017 → Jul 2018 | diabetic macular edema | YD Global Life Science Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YD312 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03635814 ↗ |